Your browser doesn't support javascript.
loading
Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia.
Genescà, E; Lazarenkov, A; Morgades, M; Berbis, G; Ruíz-Xivillé, N; Gómez-Marzo, P; Ribera, J; Juncà, J; González-Pérez, A; Mercadal, S; Guardia, R; Artola, M T; Moreno, M J; Martínez-López, J; Zamora, L; Barba, P; Gil, C; Tormo, M; Cladera, A; Novo, A; Pratcorona, M; Nomdedeu, J; González-Campos, J; Almeida, M; Cervera, J; Montesinos, P; Batlle, M; Vives, S; Esteve, J; Feliu, E; Solé, F; Orfao, A; Ribera, J M.
Affiliation
  • Genescà E; Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-Germans Trias i Pujol, Universitat Autònoma de Barcelona (UAB), Badalona, Spain. egenesca@carrerasresearch.org.
  • Lazarenkov A; ALL Research Group, Josep Carreras Leukaemia Research Institute (IJC), Camí de les Escoles s/n. Edifici IJC, 08916, Badalona, Spain. egenesca@carrerasresearch.org.
  • Morgades M; Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-Germans Trias i Pujol, Universitat Autònoma de Barcelona (UAB), Badalona, Spain.
  • Berbis G; Clinical Hematology Department, ICO-Hospital Germans Trias i Pujol, Badalona, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
  • Ruíz-Xivillé N; Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-Germans Trias i Pujol, Universitat Autònoma de Barcelona (UAB), Badalona, Spain.
  • Gómez-Marzo P; Clinical Hematology Department, ICO-Hospital Germans Trias i Pujol, Badalona, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
  • Ribera J; Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-Germans Trias i Pujol, Universitat Autònoma de Barcelona (UAB), Badalona, Spain.
  • Juncà J; Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-Germans Trias i Pujol, Universitat Autònoma de Barcelona (UAB), Badalona, Spain.
  • González-Pérez A; Clinical Hematology Department, ICO-Hospital Germans Trias i Pujol, Badalona, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
  • Mercadal S; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Research Program on Biomedical Informatics, Universitat Pompeu Fabra, Barcelona, Spain.
  • Guardia R; Clinical Hematology Service, Hospital Duran i Reynals-ICO, Hospitalet del LLobregat, Barcelona, Spain.
  • Artola MT; Clinical Hematology Service, Hospital Josep Trueta-ICO, Girona, Spain.
  • Moreno MJ; Clinical Hematology Service, Hospital Universitario de Donostia, Donostia, Spain.
  • Martínez-López J; Clinical Hematology Service, Hospital Vírgen de la Victoria, Málaga, Spain.
  • Zamora L; Hematology Department, Hospital 12 de Octubre, CNIO, Universidad Complutense, Madrid, Spain.
  • Barba P; Clinical Hematology Department, ICO-Hospital Germans Trias i Pujol, Badalona, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
  • Gil C; Clinical Hematology Service, Hospital Universitari de la Vall d'Hebron, Barcelona, Spain.
  • Tormo M; Clinical Hematology Service, Hospital General de Alicante, Alicante, Spain.
  • Cladera A; Clinical Hematology Service, Hospital Clínico de Valencia, Valencia, Spain.
  • Novo A; Clinical Hematology Service, Hospital Son Llàtzer, Palma, Spain.
  • Pratcorona M; Clinical Hematology Service, Hospital Son Espases, Palma, Spain.
  • Nomdedeu J; Clinical Hematology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • González-Campos J; Clinical Hematology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Almeida M; Clinical Hematology Service, Hospital Vírgen del Rocío, Sevilla, Spain.
  • Cervera J; Banco Nacional de ADN Carlos III, Universidad de Salamanca, Salamanca, Spain.
  • Montesinos P; Biobanco de la Fe, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, Spain.
  • Batlle M; Clinical Hematology Service, Hospital La Fe, Valencia, Spain.
  • Vives S; Clinical Hematology Department, ICO-Hospital Germans Trias i Pujol, Badalona, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
  • Esteve J; Clinical Hematology Department, ICO-Hospital Germans Trias i Pujol, Badalona, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
  • Feliu E; Clinical Hematology Service, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Solé F; Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-Germans Trias i Pujol, Universitat Autònoma de Barcelona (UAB), Badalona, Spain.
  • Orfao A; Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-Germans Trias i Pujol, Universitat Autònoma de Barcelona (UAB), Badalona, Spain.
  • Ribera JM; Centro de Investigación del Cáncer (IBMCC-CSIC/USAL) (CIC), Hospital Clínico Universitario de Salamanca (HUS), Instituto Bio-Sanitario de Salamanca (IBSAL), CIBERONC, Salamanca, Spain.
J Hematol Oncol ; 11(1): 96, 2018 07 24.
Article in En | MEDLINE | ID: mdl-30041662
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Deletion / Genes, p16 / Tumor Suppressor Protein p14ARF / Cyclin-Dependent Kinase Inhibitor p15 / Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Hematol Oncol Year: 2018 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Deletion / Genes, p16 / Tumor Suppressor Protein p14ARF / Cyclin-Dependent Kinase Inhibitor p15 / Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Hematol Oncol Year: 2018 Document type: Article